These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Monoclonal antibodies against large oval aggregates of Aβ1-42. Shimizu T; Yoshimune K; Komoriya T; Akiyama T; Ye X; Kohno H J Biosci Bioeng; 2013 Feb; 115(2):216-20. PubMed ID: 23041139 [TBL] [Abstract][Full Text] [Related]
26. Improvement of a low pH antigen-antibody dissociation procedure for ELISA measurement of circulating anti-Abeta antibodies. Li Q; Gordon M; Cao C; Ugen KE; Morgan D BMC Neurosci; 2007 Mar; 8():22. PubMed ID: 17374155 [TBL] [Abstract][Full Text] [Related]
28. Peripherally administered sera antibodies recognizing amyloid-β oligomers mitigate Alzheimer's disease-like pathology and cognitive decline in aged 3× Tg-AD mice. Wang HC; Yu YZ; Liu S; Zhao M; Xu Q Vaccine; 2016 Apr; 34(15):1758-66. PubMed ID: 26945100 [TBL] [Abstract][Full Text] [Related]
29. Conformation-dependent single-chain variable fragment antibodies specifically recognize beta-amyloid oligomers. Wang XP; Zhang JH; Wang YJ; Feng Y; Zhang X; Sun XX; Li JL; Du XT; Lambert MP; Yang SG; Zhao M; Klein WL; Liu RT FEBS Lett; 2009 Feb; 583(3):579-84. PubMed ID: 19162022 [TBL] [Abstract][Full Text] [Related]
30. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits. Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368 [TBL] [Abstract][Full Text] [Related]
31. Molecular interactions between monoclonal oligomer-specific antibody 5E3 and its amyloid beta cognates. Khorvash M; Blinov N; Ladner-Keay C; Lu J; Silverman JM; Gibbs E; Wang YT; Kovalenko A; Wishart D; Cashman NR PLoS One; 2020; 15(5):e0232266. PubMed ID: 32469918 [TBL] [Abstract][Full Text] [Related]
32. Generation and Partial Characterization of Rabbit Monoclonal Antibody to Pyroglutamate Amyloid-β3-42 (pE3-Aβ). Mehta PD; Patrick BA; Barshatzky M; Mehta SP; Frackowiak J; Mazur-Kolecka B; Wegiel J; Wisniewski T; Miller DL J Alzheimers Dis; 2018; 62(4):1635-1649. PubMed ID: 29504532 [TBL] [Abstract][Full Text] [Related]
33. Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice. Mably AJ; Liu W; Mc Donald JM; Dodart JC; Bard F; Lemere CA; O'Nuallain B; Walsh DM Neurobiol Dis; 2015 Oct; 82():372-384. PubMed ID: 26215784 [TBL] [Abstract][Full Text] [Related]